Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors

Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors

US Patent 11932658 · Granted Mar 19, 2024

Estimated economic value: $160,459,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound as porcupine inhibitor and use thereof2025
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Bicyclic heteroaryl substituted compounds2024
Bicyclic heteroaryl substituted compounds2024
Bicyclic heteroaryl substituted compounds2024
Bicyclic heteroaryl substituted compounds2024
Bicyclic heteroaryl substituted compounds2024
Biarylmethyl heterocycles2024
Biarylmethyl heterocycles2024
Biarylmethyl heterocycles2024
Biarylmethyl heterocycles2024